Healthcare

FDA Alert: Change in Reprocessing Methods for Certain Karl Storz Urological Endoscopes

The U.S. Food & Drug Administration recently issued a letter to healthcare providers regarding changes to reprocessing methods for certain urological endoscopes manufactured by Karl Storz, due to infection risk. The letter can be found here. An excerpt follows: “As the U.S. Food and Drug Administration (FDA) continues to evaluate the risk of patient infections and contamination issues associated with ...

Read More »

New Study Finds Endoscopy Equipment Market Worth $39.3 Billion

Markets and Markets Logo

According to the new market research report “Endoscopy Equipment Marketby Product (Endoscope (Flexible, Rigid, Capsule, Robot-assisted, Disposable), Visualization Systems, Accessories), Application (GI Endoscopy, Laparoscopy, Bronchoscopy, Arthroscopy), End User – Global Forecast to 2026″, published by MarketsandMarkets™, the global Endoscopy Equipment Market is projected to reach USD 39.3 billion by 2026 from USD 27.3 billion in 2021, at a CAGR of 7.5%. ...

Read More »

Geneoscopy Starts Clinical Trial for Home Colorectal-Cancer Test

ST. LOUIS, Missouri—Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal health, today announced the enrollment of its first patients in the CRC-PREVENT pivotal trial. The clinical study seeks to evaluate the safety and efficacy of Geneoscopy’s noninvasive, at-home diagnostic screening test to successfully detect colorectal neoplasms, including advanced adenomas, in average-risk individuals, a ...

Read More »

New Colorectal Cancer Screening Recommended to Begin at 45

The Colorectal Cancer Alliance (Alliance), a national nonprofit that exists to end colorectal cancer, today applauds the United States Preventive Services Task Force (USPSTF) for updating its colorectal cancer (CRC) screening guidelines in response to rising cases of CRC in younger adults. The new guidelines state that all people who are at average risk for the disease should begin screening for colorectal cancer at ...

Read More »

BD Announces the Voluntary Recall of Specified Lots of ChloraPrep™ Hi-Lite Orange™ 26 mL Applicator in the United States and U.S. Territories

BD (Becton, Dickinson and Company), a leading global medical technology company, is voluntarily recalling specified lots of the ChloraPrep™ Hi-Lite Orange™ 26 mL Applicator (2% w/w chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA)) to the user level due to a defective applicator. The product is used as an antiseptic for the preparation of the patient’s skin prior to surgery ...

Read More »